Assembloids and Neurological Medical Treatment
Dr. Sergiu Pasca, a professor of psychiatry at Stanford University, recently published research that advances the field of neuroscience and psychiatry immensely. Previously, much of the neurological information regarding conditions such as autism, epilepsy, and schizophrenia, were known, but directions for treatment have been unclear and also unspecific to neural pathways and genetic causes. Thus, Dr. Pasca's research unlocked promising details into the world of psychiatric or neurodevelopmental disorder treatment. He created brain organoids or "assembloids" as they are referred to, using stem cells to grow nervous system models similar to a brain, in which they used CRISPR gene editing techniques to target interneurons and distinguish the roles they play in various neural networks. An example of this would be which neurotransmitters are involved or inhibited (excitatory vs inhibitory), and what this could mean for psychiatric and neurodevelopmental disorders in addition to their treatment. As a result, this use of an assembloid is quite promising for medical treatments going forward, due to a particularly useful model.
Links:
https://www.npr.org/sections/health-shots/2023/10/02/1202749791/new-tool-study-genetics-autism-schizophrenia-brain-disorders
https://www.nature.com/articles/d41586-021-02628-x
No comments:
Post a Comment